incretin comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-08-02. Numbers and descriptions here follow the published literature rather than marketing material.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.
Quantification and purity assessment rely on separation methods coupled to optical or mass detection. Reversed-phase high-performance liquid chromatography resolves the intact peptide from related impurities and is the standard assay technique. Size-exclusion chromatography measures aggregates, while ion-exchange chromatography separates charge variants produced by deamidation. Mass spectrometry confirms identity and detects mass shifts of a few daltons. In biological matrices, liquid chromatography with tandem mass spectrometry is often used because immunoassays can cross-react with endogenous GLP-1 or with circulating fragments.
As a peptide, semaglutide is sensitive to conditions that break amide bonds or modify side chains. Deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation are the main degradation routes described in published stability work. Rate depends strongly on pH, buffer species, ionic strength, temperature and exposure to light. Formulators therefore choose a defined solution pH and often add excipients such as phosphate buffer, propylene glycol and phenol, each of which plays a separate role in pH control, tonicity or preservation.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | 31 amino acids |
| Backbone modification | Aib at position 8 | Blocks DPP-4 cleavage |
| Fatty acid chain | C18 diacid | Supports albumin binding |
| Native half-life | 1 to 2 minutes | Endogenous GLP-1 |
| Analog half-life | Approximately one week | Extended by albumin binding |
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
Reversed-phase high-performance liquid chromatography with ultraviolet detection is the dominant approach for peptide purity assessment, usually paired with mass spectrometry to confirm molecular mass and sequence. Peptide mapping by enzymatic digestion and tandem mass spectrometry locates modifications such as deamidation and oxidation. Quantitation in plasma matrices can be performed by LC-MS/MS after solid-phase extraction. Method validation follows general guidance on accuracy, precision, linearity, and limits of detection. Comparability of results between laboratories, when no shared reference standard is available, remains an open question.
Stability studies focus on deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation into higher-order species. The fatty acid side chain adds susceptibility to oxidative change and can promote self-association at high concentration. Lyophilised material is comparatively robust when kept cold and dry, while aqueous solutions require refrigeration and protection from light. Forced degradation experiments under heat, acid, base, and peroxide conditions establish the specificity of each analytical method. Which degradation route dominates under real storage conditions depends on the formulation and stays formulation-specific.
容器与密封系统同样参与稳定性表现。硅油涂层、胶塞材质与顶空氧含量可能改变聚集速率与氧化水平。分析结果因此需要在完整包装形式下评估，而不能仅凭原料药数据推断。法规文件通常要求同时提交批次数据与代表性容器中的稳定性趋势。
关于降解产物的免疫原性风险，文献中仍有讨论空间。体外聚集水平与临床免疫反应之间的定量关系尚未确立。多数公开研究只报告理化指标，缺少长期随访的对应数据。这一问题在生物类似物比对中尤其受到关注。
市售注射用制剂通常要求在二至八摄氏度冷藏保存，并避免光照与冻结。部分多剂量笔在首次使用后允许在不超过三十摄氏度的环境中存放有限周数，具体期限由辅料与防腐剂体系决定。反复冻融会促进肽链聚集并改变可见颗粒计数，因此应予避免。冻干粉末在干燥、避光、低温条件下更为稳定。溶液配制后宜使用低吸附容器，以减少肽类在塑料或玻璃表面的损失。
Material described as research-grade is not necessarily manufactured to pharmaceutical standards, and purity figures depend on the method used to obtain them. A certificate of analysis states the measured purity, the analytical technique, and the batch identifier, but the underlying data are not always included. Independent testing by a second laboratory is a common way to confirm identity and purity. Uncertainties remain about how storage history affects long-term stability, and about how well results from one laboratory transfer to another. Documentation of handling conditions supports comparison between batches.
Peptides are sensitive to temperature, light, oxygen, and repeated freeze-thaw cycles. Semaglutide in dry form is generally held at refrigerated temperatures, while reconstituted solutions require a defined short-term storage window. Vials should be kept in secondary packaging to limit photodegradation, and exposure to alkaline conditions is avoided because it accelerates chemical degradation. Adsorption to glass and some plastics can reduce the measured concentration of dilute solutions, so low-binding polypropylene containers are preferred for analytical work. Each transfer step introduces a small risk of contamination, and closed handling practices reduce that risk.
Routine characterisation of the peptide relies on reversed-phase high-performance liquid chromatography, often paired with ultraviolet detection near 214 nanometres. Related substances such as deamidated, oxidised, and truncated sequences elute at characteristic positions and are quantified by area percentage. Electrospray ionisation mass spectrometry confirms the molecular mass and can resolve some closely related variants. Peptide mapping after enzymatic digestion provides sequence-level verification and is useful when a full identity profile is required. Method parameters such as column chemistry, gradient, and mobile-phase pH influence the separation and must be reported alongside results.
=== Receptors === Even though much weaker than glycine (and, thus, with a debated role as a physiological transmitter), β-alanine is an agonist next in activity to the cognate ligand glycine itself, for strychnine-sensitive inhibitory glycine receptors (GlyRs) (the agonist order: glycine ≫ β-alanine > taurine ≫ alanine, L-serine > proline). β-alanine has five known receptor sites, including GABA-A, GABA-C a co-agonist site (with glycine) on NMDA receptors, the aforementioned GlyR site, and blockade of GAT protein-mediated glial GABA uptake, making it a putative "small molecule neurotransmitter."
Muammar Muhammad Abu Minyar al-Gaddafi (c. 1942 – 20 October 2011) was a Libyan military officer, revolutionary, politician, and political theorist who ruled Libya from 1969 until his overthrow by Libyan rebel forces in 2011 during the First Libyan Civil War. He came to power through a bloodless military coup, first becoming Revolutionary Chairman of the Libyan Arab Republic from 1969 to 1977, Secretary General of the General People's Congress from 1977 to 1979, and then the Brotherly Leader of the Great Socialist People's Libyan Arab Jamahiriya from 1979 to 2011. Initially ideologically committed to Arab nationalism and Arab socialism, Gaddafi later ruled according to his own Third International Theory. Gaddafi became an Arab nationalist while at school in Sabha, later enrolling in the Royal Military Academy, Benghazi. He founded a revolutionary group known as the Free Officers movement which deposed the Western-backed Senussi monarchy of Idris I in a 1969 coup. Gaddafi converted Libya into a republic governed by his Revolutionary Command Council. Ruling by decree, he deported Libya's Italian population and ejected its Western military bases. He strengthened ties to Arab nationalist governments and unsuccessfully advocated pan-Arab political union. An Islamic modernist, he introduced Sharia law and promoted Islamic socialism. He nationalized the oil industry and used the increasing state revenues to bolster the military, fund foreign revolutionaries, and implement social programs emphasizing housebuilding, healthcare and education projects.
== Hapten coupling == Haptens can be coupled to KLH using several methods. A simple one-step coupling can be performed using the carbodiimide crosslinker EDC to covalently attach carboxyls to primary amines. This method is the simplest to perform and the "random" orientation allows for antibody generation against all possible epitopes, but it generally results in some degree of polymerization, which decreases solubility making the conjugate more difficult to handle. KLH can be activated with the crosslinker Sulfo-SMCC, which converts lysine residues to sulfhydryl-reactive maleimide groups. A sulfhydryl-containing hapten can then be reacted with the KLH to complete the immunogen without causing polymerization. The specificity of this reaction is ideal for situations where the cysteine is located away from the desired epitope (e.g. in peptides where a terminal cysteine can be added to either end of the peptide). Maleimide activated KLH, where the first part of this two step procedure has been completed, is commercially available.
A Pew Research Center post-election analysis of voters who are listed as having voted in their state's voter turnout records who have also reported voting in a survey after the election similarly found a "more racially and ethnically diverse" electorate, one that was less engaged politically than in the four previous federal elections. More 2020 Trump voters (89%) than 2020 Biden voters (85%) also voted in 2024. 15% of those who voted for Biden in 2020 did not vote in the 2024 election. 78% of White voters supported Trump in 2024, a lower level of support for him among this group than in 2020 and 2016. Fewer Black voters supported Harris in 2024 than they did the Democratic candidates in the 2020 and 2016 elections.
=== EC 1.14.11 With 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors === EC 1.14.11.1: γ-butyrobetaine dioxygenase EC 1.14.11.2: procollagen-proline dioxygenase EC 1.14.11.3: pyrimidine-deoxynucleoside 2′-dioxygenase EC 1.14.11.4: procollagen-lysine 5-dioxygenase EC 1.14.11.5: Now included with EC 1.14.11.6 thymine dioxygenase EC 1.14.11.6: thymine dioxygenase EC 1.14.11.7: procollagen-proline 3-dioxygenase EC 1.14.11.8: trimethyllysine dioxygenase EC 1.14.11.9: flavanone 3-dioxygenase EC 1.14.11.10: pyrimidine-deoxynucleoside 1′-dioxygenase EC 1.14.11.11: hyoscyamine (6S)-dioxygenase EC 1.14.11.12: gibberellin-44 dioxygenase EC 1.14.11.13: gibberellin 2β-dioxygenase EC 1.14.11.14: Now EC 1.14.20.13, 6β-hydroxyhyoscyamine epoxidase EC 1.14.11.15: gibberellin 3β-dioxygenase EC 1.14.11.16: peptide-aspartate β-dioxygenase EC 1.14.11.17: taurine dioxygenase EC 1.14.11.18: phytanoyl-CoA dioxygenase EC 1.14.11.19: Now EC 1.14.20.4, anthocyanidin synthase EC 1.14.11.20: deacetoxyvindoline 4-hydroxylase EC 1.14.11.21: clavaminate synthase EC 1.14.11.22: Now EC 1.14.20.5, flavone synthase EC 1.14.11.23: Now EC 1.14.20.6, flavonol synthase EC 1.14.11.24: 2′-deoxymugineic-acid 2′-dioxygenase EC 1.14.11.25: mugineic-acid 3-dioxygenase EC 1.14.11.26: deacetoxycephalosporin-C hydroxylase EC 1.14.11.27: [histone H3]-dimethyl-L-lysine36 demethylase EC 1.14.11.28: proline 3-hydroxylase EC 1.14.11.29: hypoxia-inducible factor-proline dioxygenase EC 1.14.11.30: hypoxia-inducible factor-asparagine dioxygenase EC 1.14.11.31: thebaine 6-O-demethylase EC 1.14.11.32: codeine 3-O-demethylase EC 1.14.11.33: DNA oxidative demethylase EC 1.14.11.34: Now EC 1.14.20.7, 2-oxoglutarate/L-arginine monooxygenase/decarboxylase (succinate-forming) EC 1.14.11.35: 1-deoxypentalenic acid 11β-hydroxylase EC 1.14.11.36: pentalenolactone F synthase EC 1.14.11.36: pentalenolactone F synthase EC 1.14.11.37: kanamycin B dioxygenase EC 1.14.11.38: verruculogen synthase EC 1.14.11.39: L-asparagine hydroxylase EC 1.14.11.40: enduracididine β-hydroxylase EC 1.14.11.41: L-arginine hydroxylase EC 1.14.11.42: tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase EC 1.14.11.43: (S)-dichlorprop dioxygenase (2-oxoglutarate) EC 1.14.11.44: (R)-dichlorprop dioxygenase (2-oxoglutarate) EC 1.14.11.45: L-isoleucine 4-hydroxylase EC 1.14.11.46: 2-aminoethylphosphonate dioxygenase EC 1.14.11.47: [50S ribosomal protein L16]-arginine 3-hydroxylase EC 1.14.11.48: xanthine dioxygenase EC 1.14.11.49: uridine-5′-phosphate dioxygenase EC|1.14.11.50: Now EC 1.14.20.8, (–)-deoxypodophyllotoxin synthase EC 1.14.11.51: DNA N6-methyladenine demethylase EC 1.14.11.52: validamycin A dioxygenase EC 1.14.11.53: mRNA N6-methyladenine demethylase EC 1.14.11.54: mRNA N1-methyladenine demethylase EC 1.14.11.55: ectoine hydroxylase EC 1.14.11.56: L-proline cis-4-hydroxylase EC 1.14.11.57: L-proline trans-4-hydroxylase EC 1.14.11.58: ornithine lipid ester-linked acyl 2-hydroxylase EC 1.14.11.59: 2,4-dihydroxy-1,4-benzoxazin-3-one-glucoside dioxygenase EC 1.14.11.60: scopoletin 8-hydroxylase EC 1.14.11.61: feruloyl-CoA 6-hydroxylase EC 1.14.11.62: trans-4-coumaroyl-CoA 2-hydroxylase EC 1.14.11.63: peptidyl-lysine (3S)-dioxygenase EC 1.14.11.64: glutarate dioxygenase EC 1.14.11.65: [histone H3]-dimethyl-L-lysine9 demethylase EC 1.14.11.66: [histone H3]-trimethylL-lysine9 demethylase EC 1.14.11.67: [histone H3]-trimethyl-LL-lysine4 demethylase EC 1.14.11.68: [histone H3]-trimethyl-L-lysine27 demethylase EC 1.14.11.69: [histone H3]-trimethyl-L-lysine37 demethylase EC 1.14.11.70: 7-deoxycylindrospermopsin hydroxylase EC 1.14.11.71: methylphosphonate hydroxylase EC 1.14.11.72: [2-(trimethylamino)ethyl]phosphonate dioxygenase EC 1.14.11.73: [protein]-arginine 3-hydroxylase EC 1.14.11.74: L-isoleucine 31-dioxygenase EC 1.14.11.75: 31-hydroxy-L-isoleucine 4-dioxygenase EC 1.14.11.76: L-glutamate 3(R)-hydroxylase EC 1.14.11.77: alkyl sulfatase
Sources: en.wikipedia.org
==== Dosage ==== Colistin sulfate and colistimethate sodium may both be given intravenously, but the dosing is complicated. The different labeling of the parenteral products of colistin methanesulfonate in different parts of the world was noted by Li et al. Colistimethate sodium manufactured by Xellia (Colomycin injection) is prescribed in international units, whereas colistimethate sodium manufactured by Parkdale Pharmaceuticals (Coly-Mycin M Parenteral) is prescribed in milligrams of colistin base:
Hiroaki Suga (菅 裕明, born February 21, 1963) is a Japanese biochemist and businessman. He is best known for his work on artificial ribozymes (flexizymes) and their application in mRNA display (RaPID, random nonstandard peptide integrated discovery). Suga was awarded the 2023 Wolf Prize in Chemistry, jointly with Chuan He and Jeffery W. Kelly, "for pioneering discoveries that illuminate the functions and pathological dysfunctions of RNA and proteins and for creating strategies to harness the capabilities of these biopolymers in new ways to ameliorate human diseases."
Camptocormia is being increasingly found in patients with Parkinson's disease. The diagnosis of Parkinson's-associated camptocormia includes the use of imaging of the brain and the spinal cord, along with electromyography or muscle biopsies. Muscle biopsies are also a useful tool to diagnose camptocormia. Muscle biopsies found to have variable muscle fiber sizes and even endomysial fibrosis may be markers of bent spine syndrome. In addition, disorganized internal architecture and little necrosis or regeneration is a marker of camptocormia. Patients with camptocormia present with reduced strength and stooped posture when standing due to weakened paraspinous muscles (muscles parallel to the spine). Clinically, limb muscles show fatigue with repetitive movements. Paraspinous muscles undergo fat infiltration. Electromyography may be used as well in diagnosis. On average, the paraspinous muscles of affected individuals were found to be 75% myopathic, while limb muscles were 50% percent myopathic. Creatine kinase activity levels in skeletal muscle are a diagnostic indicator that can be identifiable through blood tests.
Protection of European consumers has been a central part of developing the EU internal market. The Treaty on the Functioning of the European Union article 169 enables the EU to follow the ordinary legislative procedure to protect consumers "health, safety and economic interests" and promote rights to "information, education and to organise themselves in order to safeguard their interests". All member states may grant higher protection, and a "high level of consumer protection" is regarded as a fundamental right. Beyond these general principles, and outside specific sectors, there are four main Directives: the Product Liability Directive 1985, Unfair Terms in Consumer Contracts Directive 1993, Unfair Commercial Practices Directive 2005 and the Consumer Rights Directive 2011, requiring information and cancellation rights for consumers. As a whole, the law is designed to ensure that consumers in the EU are entitled to the same minimum rights wherever they shop, and largely follows inspiration from theories of consumer protection developed in California and the Consumer Bill of Rights proclaimed by John F. Kennedy in 1962. The Court of Justice has continually affirmed that the need for more consumer rights (than in commercial contracts) both because consumers tend to lack information, and they have less bargaining power.
Sources: en.wikipedia.org
It is a synthetic analog of GLP-1 produced through medicinal chemistry to resist enzymatic degradation. The design goal was longer circulation than the native hormone.
A fatty acid side chain attaches the peptide to serum albumin, which shields it from kidney filtration and protease activity. This interaction is the main reason its circulation time is extended.
No. The native hormone is GLP-1, and semaglutide is an engineered variant with three deliberate structural alterations. It does not appear in unmodified biological sources.
Ice formation concentrates solutes and can mechanically stress the peptide or damage the delivery device. Thawing afterwards may leave aggregates that are not visible to the eye. Refrigeration keeps the solution above its freezing point while slowing chemical degradation.